Ulysses Diva

1.7k total citations
29 papers, 706 citations indexed

About

Ulysses Diva is a scholar working on Nephrology, Gastroenterology and Urology. According to data from OpenAlex, Ulysses Diva has authored 29 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 8 papers in Gastroenterology and 4 papers in Urology. Recurrent topics in Ulysses Diva's work include Renal Diseases and Glomerulopathies (8 papers), Gastroesophageal reflux and treatments (7 papers) and Gastrointestinal motility and disorders (6 papers). Ulysses Diva is often cited by papers focused on Renal Diseases and Glomerulopathies (8 papers), Gastroesophageal reflux and treatments (7 papers) and Gastrointestinal motility and disorders (6 papers). Ulysses Diva collaborates with scholars based in United States, United Kingdom and Finland. Ulysses Diva's co-authors include Mark Sostek, Jaakko Lappalainen, Jan Tack, Tim Morse, Lynn R. Webster, Raj Tummala, William D. Chey, Radko Komers, Charles Dillon and Richard B. Wilber and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of the American Society of Nephrology.

In The Last Decade

Ulysses Diva

26 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ulysses Diva United States	12	203	197	158	130	128	29	706
A F Muller United Kingdom	16	144 0.7×	26 0.1×	81 0.5×	18 0.1×	238 1.9×	34	652
Niels Krarup Denmark	18	406 2.0×	263 1.3×	52 0.3×	48 0.4×	502 3.9×	58	1.1k
Fehmi Ateş Türkiye	14	112 0.6×	109 0.6×	250 1.6×	6 0.0×	308 2.4×	41	622
Mustafa İhsan Uslan Türkiye	11	122 0.6×	70 0.4×	52 0.3×	12 0.1×	160 1.3×	54	425
Darryl T. Hiyama United States	17	83 0.4×	23 0.1×	41 0.3×	10 0.1×	369 2.9×	29	769
Bin Xia China	12	95 0.5×	6 0.0×	94 0.6×	17 0.1×	133 1.0×	44	512
Amro M. Abdelrahman United States	12	39 0.2×	11 0.1×	6 0.0×	150 1.2×	235 1.8×	45	471
Rolf Busund Norway	14	235 1.2×	14 0.1×	2 0.0×	22 0.2×	123 1.0×	37	799
M. Mushfiqur Rahman Canada	13	120 0.6×	12 0.1×	6 0.0×	127 1.0×	167 1.3×	20	740
Maria Cândida Ribeiro Parisi Brazil	15	53 0.3×	3 0.0×	36 0.2×	23 0.2×	101 0.8×	58	610

Countries citing papers authored by Ulysses Diva

Since Specialization

Citations

This map shows the geographic impact of Ulysses Diva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulysses Diva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulysses Diva more than expected).

Fields of papers citing papers by Ulysses Diva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulysses Diva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulysses Diva. The network helps show where Ulysses Diva may publish in the future.

Co-authorship network of co-authors of Ulysses Diva

This figure shows the co-authorship network connecting the top 25 collaborators of Ulysses Diva. A scholar is included among the top collaborators of Ulysses Diva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulysses Diva. Ulysses Diva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mariani, Laura, Howard Trachtman, Aliza Thompson, et al.. (2024). Proteinuria as an End Point in Clinical Trials of Focal Segmental Glomerulosclerosis. American Journal of Kidney Diseases. 85(5). 610–617. 1 indexed citations

Trachtman, Howard, Ulysses Diva, Edward Murphy, et al.. (2023). Implications of Complete Proteinuria Remission at any Time in Focal Segmental Glomerulosclerosis: Sparsentan DUET Trial. Kidney International Reports. 8(10). 2017–2028. 6 indexed citations

Bensink, Mark, et al.. (2023). #4499 MATCHING-ADJUSTED INDIRECT COMPARISON OF SPARSENTAN VS DELAYED-RELEASE FORMULATION BUDESONIDE FOR PROTEINURIA REDUCTION IN ADULTS WITH IGA NEPHROPATHY. Nephrology Dialysis Transplantation. 38(Supplement_1).

Freedman, Sharon F., Monte A. Del Monte, Ulysses Diva, et al.. (2023). Prevalence of cerebrotendinous xanthomatosis among patients diagnosed with early-onset idiopathic bilateral cataracts: final analysis. Journal of American Association for Pediatric Ophthalmology and Strabismus. 27(4). 208–211.

Inker, Lesley A., Hiddo J.L. Heerspink, Hocine Tighiouart, et al.. (2021). Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis. American Journal of Kidney Diseases. 78(3). 340–349.e1. 45 indexed citations

Komers, Radko, Ulysses Diva, Jula K. Inrig, et al.. (2020). Study Design of the Phase 3 Sparsentan Versus Irbesartan (DUPLEX) Study in Patients With Focal Segmental Glomerulosclerosis. Kidney International Reports. 5(4). 494–502. 40 indexed citations

Barratt, Jonathan, Brad H. Rovin, Ulysses Diva, Alex Mercer, & Radko Komers. (2019). Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial). Kidney International Reports. 4(11). 1633–1637. 23 indexed citations

White, William B., Peter R. Kowey, Ulysses Diva, Mark Sostek, & Raj Tummala. (2018). Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation. Journal of Cardiovascular Pharmacology and Therapeutics. 23(4). 309–317. 10 indexed citations

Webster, Lynn R., Ulysses Diva, Raj Tummala, & Mark Sostek. (2017). Treatment with Naloxegol Versus Placebo: Pain Assessment in Patients with Noncancer Pain and Opioid‐Induced Constipation. Pain Practice. 18(4). 505–514. 10 indexed citations

10.

Webster, Lynn R., Raj Tummala, Ulysses Diva, & Jaakko Lappalainen. (2016). A 12-week extension study to assess the safety and tolerability of naloxegol in patients with noncancer pain and opioid-induced constipation. Journal of Opioid Management. 12(6). 405–419. 15 indexed citations

11.

Tack, Jan, Jaakko Lappalainen, Ulysses Diva, Raj Tummala, & Mark Sostek. (2015). Efficacy and safety of naloxegol in patients with opioid‐induced constipation and laxative‐inadequate response. United European Gastroenterology Journal. 3(5). 471–480. 42 indexed citations

12.

Tummala, Raj, Ulysses Diva, & Mark Sostek. (2015). Sa1398 Treatment With Naloxegol Versus Placebo: Safety Assessment in Patients Aged ≥65 Years With Noncancer Pain and Opioid-Induced Constipation. Gastroenterology. 148(4). S–314. 4 indexed citations

13.

Webster, Lynn R., William D. Chey, Jan Tack, et al.. (2014). Randomised clinical trial: the long‐term safety and tolerability of naloxegol in patients with pain and opioid‐induced constipation. Alimentary Pharmacology & Therapeutics. 40(7). 771–779. 92 indexed citations

14.

Cherniack, Martin G., Ronnie Lundström, Tim Morse, et al.. (2008). The effect of different warming methods on sensory nerve conduction velocity in shipyard workers occupationally exposed to hand–arm vibration. International Archives of Occupational and Environmental Health. 81(8). 1045–1058. 7 indexed citations

15.

Leung, Nancy, Chung‐Kang Peng, Hie‐Won Hann, et al.. (2008). Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis B. Hepatology. 49(1). 72–79. 146 indexed citations

16.

Leung, Nancy, Cheng‐Yuan Peng, Jose D. Sollano, et al.. (2008). 998 ENTECAVIR (ETV) RESULTS IN HIGHER HBV DNA REDUCTION VERSUS ADEFOVIR (ADV) IN ANTIVIRAL-NAIVE HBEAG(+) ADULTS WITH HIGH HBVDNA: WEEK 96 RESULTS (E.A.R.L.Y. STUDY). Journal of Hepatology. 48. S373–S374. 10 indexed citations

17.

Morse, Tim, Nicholas Warren, Charles Dillon, & Ulysses Diva. (2007). A population based survey of ergonomic risk factors in Connecticut: distribution by industry, occupation, and demographics.. PubMed. 71(5). 261–8. 5 indexed citations

18.

Diva, Ulysses, Sudipto Banerjee, & Dipak Dey. (2007). Modelling spatially correlated survival data for individuals with multiple cancers. Statistical Modelling. 7(2). 191–213. 10 indexed citations

19.

Cherniack, Martin G., Ronnie Lundström, Tim Morse, et al.. (2007). Syndromes from segmental vibration and nerve entrapment: observations on case definitions for carpal tunnel syndrome. International Archives of Occupational and Environmental Health. 81(5). 661–669. 5 indexed citations

20.

Morse, Tim, et al.. (2005). Trends in work-related musculoskeletal disorder reports by year, type, and industrial sector: A capture-recapture analysis. American Journal of Industrial Medicine. 48(1). 40–49. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact